Chen Yi-Bin, Kim Haesook T, McDonough Sean, Odze Robert D, Yao Xiaopan, Lazo-Kallanian Suzan, Spitzer Thomas R, Soiffer Robert, Antin Joseph H, Ritz Jerome
Department of Hematology/Oncology, Division of Bone Marrow Transplantation, Massachusetts General Hospital, Boston, MA, USA.
Biol Blood Marrow Transplant. 2009 Sep;15(9):1066-76. doi: 10.1016/j.bbmt.2009.05.003. Epub 2009 Jul 8.
Acute graft-versus-host disease (aGVHD) is a major complication after hematopoietic stem cell transplantation (HSCT). The pathophysiology of aGVHD involves priming of naïve donor T cells in host secondary lymphoid tissue, followed by migration of effector T cells to target organs. Mediators of lymphocyte trafficking are believed to play a significant role in this migration. In this retrospective case-controlled study, we analyzed the expression of alpha4beta7 integrin and CCR9, 2 surface T cell molecules specific for intestinal trafficking, from blood samples collected previously from 59 patients after HSCT (20 without aGVHD, 20 with skin aGVHD, and 19 with intestinal aGVHD). All samples had been obtained before the onset of aGVHD symptoms (with 1 sample collected on the day of symptom onset). Analysis by flow cytometry demonstrated that alpha4beta7 integrin was significantly increased on both naïve and memory T cells in patients who subsequently developed intestinal aGVHD, with the most significant differences observed in memory subsets. Immunohistochemical staining on rectal biopsy specimens from patients with intestinal aGVHD showed that expression of alpha4beta7 integrin was concentrated on mononuclear cells in blood vessels within the intestinal mucosa. These results suggest that alpha4beta7 integrin likely is involved in lymphocyte trafficking in intestinal aGVHD and may have potential clinical use as a correlative biomarker or as a target for the treatment and prophylaxis of intestinal aGVHD after HSCT.
急性移植物抗宿主病(aGVHD)是造血干细胞移植(HSCT)后的一种主要并发症。aGVHD的病理生理学涉及宿主二级淋巴组织中幼稚供体T细胞的致敏,随后效应T细胞迁移至靶器官。淋巴细胞归巢介质被认为在这种迁移中起重要作用。在这项回顾性病例对照研究中,我们分析了59例HSCT术后患者(20例无aGVHD,20例有皮肤aGVHD,19例有肠道aGVHD)之前采集的血样中α4β7整合素和CCR9这两种肠道归巢特异性表面T细胞分子的表达情况。所有样本均在aGVHD症状出现前采集(1例样本在症状出现当天采集)。流式细胞术分析表明,随后发生肠道aGVHD的患者中,幼稚T细胞和记忆T细胞上的α4β7整合素均显著增加,在记忆亚群中观察到的差异最为显著。对肠道aGVHD患者的直肠活检标本进行免疫组织化学染色显示,α4β7整合素的表达集中在肠黏膜内血管中的单核细胞上。这些结果表明,α4β7整合素可能参与肠道aGVHD中的淋巴细胞归巢,并且可能具有作为相关生物标志物或作为HSCT后肠道aGVHD治疗和预防靶点的潜在临床用途。